Publication details

Srovnání nových antipsychotik (lurasidonu, kariprazinu a brexpiprazolu) z klinického úhlu pohledu

Title in English Comparison of new antipsychotics (lurasidone, cariprazine and brexpiprazole) from the clinical point of view
Authors

USTOHAL Libor

Year of publication 2021
Type Article in Periodical
Magazine / Source Psychiatrie pro praxi
MU Faculty or unit

Faculty of Medicine

Citation
Web https://www.solen.cz/artkey/psy-202102-0004_srovnani_novych_antipsychotik_lurasidonu_kariprazinu_a_brexpiprazolu_z_klinickeho_uhlu_pohledu.php?back=%2Fsearch.php%3Fquery%3DREUMATOIDN%2525ED%252520ARTRIT%2525EDDA%26sfrom%3D60%26spage%3D30
Keywords brexpiprazole; cariprazine; lurasidone; efficacy; side effects; schizophrenia
Description Three new antipsychotics - cariprazine, lurasidone and brexpiprazole - have been introduced to the Czech market in the past two years. This review article aims to compare them from a clinical point of view. It focuses on their basic characteristics including receptors profile, indications and efficacy, dosage including dose-response relationship and, last but not least, on their tolerability and side effects.

You are running an old browser version. We recommend updating your browser to its latest version.

More info